BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 26769968)

  • 21. Prions on the run: How extracellular vesicles serve as delivery vehicles for self-templating protein aggregates.
    Liu S; Hossinger A; Göbbels S; Vorberg IM
    Prion; 2017 Mar; 11(2):98-112. PubMed ID: 28402718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular prion protein released on exosomes from macrophages binds to Hsp70.
    Wang G; Zhou X; Bai Y; Zhang Z; Zhao D
    Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):345-50. PubMed ID: 20458448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of Infectious Prions and Detection with the Prion-Infected Cell Assay.
    Vella LJ; Coleman B; Hill AF
    Methods Mol Biol; 2017; 1658():105-118. PubMed ID: 28861786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipose tissue browning in cancer-associated cachexia can be attenuated by inhibition of exosome generation.
    Hu W; Ru Z; Xiao W; Xiong Z; Wang C; Yuan C; Zhang X; Yang H
    Biochem Biophys Res Commun; 2018 Nov; 506(1):122-129. PubMed ID: 30340833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axonal and transynaptic spread of prions.
    Shearin H; Bessen RA
    J Virol; 2014 Aug; 88(15):8640-55. PubMed ID: 24850738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome release from infected dendritic cells: a clue for a fast spread of prions in the periphery?
    Klöhn PC; Castro-Seoane R; Collinge J
    J Infect; 2013 Nov; 67(5):359-68. PubMed ID: 23911964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells.
    Bellingham SA; Coleman BM; Hill AF
    Nucleic Acids Res; 2012 Nov; 40(21):10937-49. PubMed ID: 22965126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platinum Nanoparticles Enhance Exosome Release in Human Lung Epithelial Adenocarcinoma Cancer Cells (A549): Oxidative Stress and the Ceramide Pathway are Key Players.
    Gurunathan S; Kang MH; Jeyaraj M; Kim JH
    Int J Nanomedicine; 2021; 16():515-538. PubMed ID: 33519199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large extracellular vesicles transfer more prions and infect cell culture better than small extracellular vesicles.
    Soukup J; Moško T; Kereïche S; Holada K
    Biochem Biophys Res Commun; 2023 Dec; 687():149208. PubMed ID: 37949026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transwell assay that excludes exosomes for assessment of tunneling nanotube-mediated intercellular communication.
    Thayanithy V; O'Hare P; Wong P; Zhao X; Steer CJ; Subramanian S; Lou E
    Cell Commun Signal; 2017 Nov; 15(1):46. PubMed ID: 29132390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid.
    Vella LJ; Greenwood DL; Cappai R; Scheerlinck JP; Hill AF
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):385-93. PubMed ID: 18501435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome secretion is a key pathway for clearance of pathological TDP-43.
    Iguchi Y; Eid L; Parent M; Soucy G; Bareil C; Riku Y; Kawai K; Takagi S; Yoshida M; Katsuno M; Sobue G; Julien JP
    Brain; 2016 Dec; 139(Pt 12):3187-3201. PubMed ID: 27679482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of miRNA expression profiles in exosomes of SMB-S15 cells treated with resveratrol.
    Shi Q; Zhang L; Wulayin X; Cao R; Jiao M; Wang J; Han J; Dong XP; Gao C
    Arch Virol; 2023 Oct; 168(11):270. PubMed ID: 37805966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.